Israel In Talks With Pfizer Over Potential COVID-19 Vaccine, PM Says

Israel In Talks With Pfizer Over Potential COVID-19 Vaccine, PM Says

"The vaccine is really the light at the end of the tunnel", Dr. Anthony Fauci, the top US infectious diseases expert said. The FDA did not respond to requests for comment. The preliminary Pfizer and BioNTech trial result was based on 94 infected volunteers.

The results come as the virus is running rampant in the United States, Europe and elsewhere, placing an enormous strain on healthcare systems with record numbers of new cases and hospitalizations.

Global shares rose as the trial results countered concerns around the soaring infection rate. The moves were small, however, compared with the jump when Pfizer first announced the vaccine was more than 90% effective on November 9. Moderna shares fell 3.6%.

Moderna, part of the USA government's Operation Warp Speed program, expects to produce about 20 million doses for the United States this year, millions of which the company has already made and is ready to ship if it gets FDA authorization.

Investors have treated vaccine development as a race between companies, although there is likely to be global demand for as much vaccine as can be produced for the foreseeable future.

Afeyan said around 10 to 20 million doses would be distributed through the supply chain before the end of 2020 and around 50 million doses by the first quarter of 2021.

Pizza shop worker's lie sparks COVID lockdown in Australia
When asked about whether the doctor was a hero at a press conference this morning, Dr Spurrier said she was actually a "heroine". South Australia will revert to a series of similar restrictions imposed at the beginning of the week from midnight on Saturday.

Pfizer also has agreements with the European Union, Germany and Japan where distribution could begin next year.

V K Paul, member-health, NITI Aayog, and also the chairman of the committee on vaccine administration, said: "The vaccine needs to be kept in -70-degree Celsius temperature and will be hard for countries to scale up". It can be stored for up to five days at standard refrigerator temperatures or for up to 15 days in a thermal shipping box.

Moderna expects the vaccine to be stable at normal fridge temperatures of 2 to 8 degrees Celsius (36 to 48°F) for 30 days and it can be stored for up to 6 months at -20C.

"The Commission has secured to date at least 1.2 billion doses and fulfils its commitment to ensuring equitable access to safe, effective and affordable vaccines not only for EU citizens but also for the world's poorest and most vulnerable people", said Ursula von der Leyen, president of the European Commission. The only severe adverse events experienced by volunteers were fatigue (3.8%) and headaches (2%) after the second dose. Older adults tended to report fewer and milder solicited adverse events following vaccination. And it's a good outcome as far as safety is concerned...

Ten people developed severe COVID-19, one of whom received the vaccine.

"We will need to wait and learn over time how long the protection lasts, and to see whether this vaccine can also prevent transmission - meanwhile, this vaccine does look likely to have a strong role immediately once it is approved in protecting health workers and the vulnerable from disease". Johnson & Johnson JNJ.N says it is on track to deliver data this year. Only Pfizer has started vaccinating volunteers under age 18 and as young as 12. Most of these complaints were generally short-lived, Moderna said.

Related Articles